- Trials with a EudraCT protocol (1,178)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,178 result(s) found for: Secondary Immune Response.
Displaying page 1 of 59.
EudraCT Number: 2021-002789-42 | Sponsor Protocol Number: IMMUNE | Start Date*: 2021-07-08 |
Sponsor Name:Medizinische Universität Innsbruck | ||
Full Title: Analysis and characterization of the immune response after influenza, SARS-CoV-2 and pneumococcal vaccinations (IMMUNE Study) | ||
Medical condition: Analysis and characterization of the immune response after influenza, SARS-CoV-2 and pneumococcal vaccinations (IMMUNE Study) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003034-42 | Sponsor Protocol Number: ALX0061-C203 | Start Date*: 2015-05-08 | |||||||||||
Sponsor Name:Ablynx NV | |||||||||||||
Full Title: A Phase II Multicenter, Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of Subcutaneous ALX-0061 in Subjects with Moderate to Severe Rheumatoid Arthritis who Have Completed O... | |||||||||||||
Medical condition: Rheumatoid Arthritis (RA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) ES (Completed) BG (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003012-36 | Sponsor Protocol Number: ALX0061-C202 | Start Date*: 2015-03-23 | |||||||||||
Sponsor Name:Ablynx NV | |||||||||||||
Full Title: A Phase IIb Multicenter, Randomized, Double-blind Study of ALX-0061 Administered Subcutaneously as Monotherapy, in Subjects with Moderate to Severe Rheumatoid Arthritis who are Intolerant to Methot... | |||||||||||||
Medical condition: Rheumatoid Arthritis (RA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) HU (Completed) CZ (Completed) ES (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003033-26 | Sponsor Protocol Number: ALX0061-C201 | Start Date*: 2015-03-23 | |||||||||||
Sponsor Name:Ablynx NV | |||||||||||||
Full Title: A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination with Methotrexate, in Subjects with Moderate to... | |||||||||||||
Medical condition: Rheumatoid Arthritis (RA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) CZ (Completed) DE (Completed) ES (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004891-33 | Sponsor Protocol Number: T33/2021 | Start Date*: 2022-04-13 |
Sponsor Name:Turku University Hospital | ||
Full Title: COVID-19 vaccine induced immune response in patients with primary antibody deficiency | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005026-30 | Sponsor Protocol Number: SB4-G31-RA | Start Date*: 2013-08-15 | |||||||||||
Sponsor Name:Samsung Bioepis Co., Ltd. | |||||||||||||
Full Title: A Randomised, Double-Blind, Parallel Group, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity of SB4 Compared to Enbrel® in Subjects with Moderate to ... | |||||||||||||
Medical condition: Subjects with Moderate to Severe Rheumatoid Arthritis despite Methotrexate Therapy. The intended use of SB4 is Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), Psoriatic Arthritis (P... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) LT (Completed) CZ (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001648-12 | Sponsor Protocol Number: OVG2015/02 | Start Date*: 2015-09-03 |
Sponsor Name:University of Oxford | ||
Full Title: A phase II, open label trial to describe immune and transcriptional responses to MF59 adjuvanted trivalent influenza vaccine (ATIV) in 13-24 month healthy children and adults 18-65 years | ||
Medical condition: This trial is investigating healthy children and adult's gene expression and immune response to the Fluad (MF59)-adjuvanted trivalent influenza vaccine and also comparing these to the local and gen... | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-004489-23 | Sponsor Protocol Number: NVI-248 | Start Date*: 2008-10-20 |
Sponsor Name:Netherlands Vaccine Institute | ||
Full Title: Development of cellular immune response after infant pneumococcal conjugate vaccinations | ||
Medical condition: Cellular immune response(long term memory) after following the infant immunisation programme with a pneumococcal conjugate vaccine (Prevenar). | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001391-42 | Sponsor Protocol Number: Speed-Covid | Start Date*: 2021-05-12 |
Sponsor Name:Medical University of Graz | ||
Full Title: Characterisation of the effects of Spermidine on the immune response to Covid-19 vaccine in older people - a feasibility study | ||
Medical condition: For assessing the immune cell function after COVID-19 vaccine, peripheral blood mononuclear cells (PBMC) will be separated after blood sampling and measurements as follows will be done: • FACS anal... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-004419-14 | Sponsor Protocol Number: T125/2020 | Start Date*: 2021-10-18 |
Sponsor Name:Turku University Hospital | ||
Full Title: COVID-19 infections in hospital personnel | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000515-24 | Sponsor Protocol Number: NL76470.078.21 | Start Date*: 2021-02-15 | |||||||||||
Sponsor Name:Erasmus University Medical Center | |||||||||||||
Full Title: Vaccination Against Covid in Primary Immune Deficiencies | |||||||||||||
Medical condition: Patients with primary immunodeficiency disease, also known as inborn errors pf immunity, are vaccinated against COVID-19 using COVID-19 Vaccine Moderna. The vaccine has been approved for use in the... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000683-30 | Sponsor Protocol Number: CoVacc | Start Date*: 2021-03-03 |
Sponsor Name:Umeå university | ||
Full Title: CoVacc - Immune response to vaccination against Covid-19, an open multicenter phase IV study | ||
Medical condition: Individuals with and without pre-existing immunity to Covid-19. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000302-10 | Sponsor Protocol Number: UHKT-COVID19 | Start Date*: 2022-01-24 |
Sponsor Name:Institute of hematology and blood transfusion | ||
Full Title: Significance of T cell response to vaccination against SARS-CoV2 for leukemic patients with weakend immune system | ||
Medical condition: Recipients of cell therapy (allo HSCT, CAR19 T cells) indicated to vaccination against COVID19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004016-26 | Sponsor Protocol Number: Clin_COVID-19_Corok | Start Date*: 2021-10-18 |
Sponsor Name:Meilahti Vaccine Research Center - Helsinki University Hospital | ||
Full Title: Substudy "Responses to Covid-19 vaccines" in research "Clinical picture, immunology, genetics and pathogenesis of COVID-19 infection" | ||
Medical condition: None | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004436-36 | Sponsor Protocol Number: Rituximab1.5 | Start Date*: 2013-04-19 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: A prospective pilotstudy of immunological and radiological effects of intrathecal rituximab in patients with secondary progressive multiple sclerosis | |||||||||||||
Medical condition: Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005459-18 | Sponsor Protocol Number: SP122PM2201 | Start Date*: 2015-09-10 | |||||||||||
Sponsor Name:SMARTPRACTICE | |||||||||||||
Full Title: Clinical Evaluation of Metal Panel Allergens Mercury, Aluminum and Palladium Dose Response Study | |||||||||||||
Medical condition: Diagnosis of Allergic Contact Dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004486-41 | Sponsor Protocol Number: 20130401 | Start Date*: 2013-01-29 |
Sponsor Name:Karolinska University Hospital, Huddinge, Sweden | ||
Full Title: Vaccination of antibody deficient patients with Prevenar13 - a comparative study between antibody response and cellular immunity. | ||
Medical condition: Patients with IgG-deficiency | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001387-20 | Sponsor Protocol Number: ELA026-CP002 | Start Date*: 2021-10-11 | ||||||||||||||||
Sponsor Name:Electra Therapeutics, Inc. | ||||||||||||||||||
Full Title: A Phase 1b, Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Multiple Doses of ELA026 in Adults and Adolescents with Secondary Hemophagocytic Lymph... | ||||||||||||||||||
Medical condition: sHLH is a rare and life-threatening inflammatory syndrome characterized by dysregulated immune function. The disease is associated with a massive systemic inflammatory response for which patients r... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021863-34 | Sponsor Protocol Number: RHMCAN0739 | Start Date*: 2011-02-10 |
Sponsor Name:University Hospital Southampton NHS Foundation Trust | ||
Full Title: A phase II trial of the addition of ipilumimab to carboplatin and etoposide chemotherapy for the first line treatment of extensive small cell lung cancer | ||
Medical condition: Extensive stage small cell lung cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001923-30 | Sponsor Protocol Number: TN-20 | Start Date*: 2016-09-26 | |||||||||||
Sponsor Name:TRIALNET COORDINATING CENTER AT THE UNIVERSITY OF SOUTH FLORIDA | |||||||||||||
Full Title: Exploring Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus | |||||||||||||
Medical condition: Type 1 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.